Editorial: Multiomic approaches in atherosclerosis

Affiliations

¹ Department of Medical Biochemistry, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia; Cardiovascular Research Unit, Department of Precision Health, Luxembourg Institute of Health, Strassen, Luxembourg. Electronic address: Miron.sopic@pharmacy.bg.ac.rs.
² Centre for Cardiovascular Science, Queen's Medical Research Institute (QMRI), University of Edinburgh, 47 Little France, Bioquarter, Edinburgh EH16 4TJ, United Kingdom.
³ Centre for Cardiovascular Science, Queen's Medical Research Institute (QMRI), University of Edinburgh, 47 Little France, Bioquarter, Edinburgh EH16 4TJ, United Kingdom; Department of Pathology, Experimental Vascular Pathology Group, Maastricht University, PO box 5800, 6202 AZ, Maastricht, the Netherlands; Department for Renal and Hypertensive, Rheumatological and Immunological Diseases (Medical Clinic II), RWTH Aachen, Aachen, Germany.
⁴ Department of Pharmacological and Biomolecular Sciences 'Rodolfo Paoletti', Università degli Studi di Milano, Milan, Italy; IRCCS MultiMedica, Milan, Italy.
⁵ Cardiovascular Research Unit, Department of Precision Health, Luxembourg Institute of Health, Strassen, Luxembourg.

Editorial

Miron Sopić et al. Vascul Pharmacol. 2025 Jun.

. 2025 Jun:159:107501.

doi: 10.1016/j.vph.2025.107501. Epub 2025 May 9.

¹ Department of Medical Biochemistry, Faculty of Pharmacy, University of Belgrade, Belgrade, Serbia; Cardiovascular Research Unit, Department of Precision Health, Luxembourg Institute of Health, Strassen, Luxembourg. Electronic address: Miron.sopic@pharmacy.bg.ac.rs.
² Centre for Cardiovascular Science, Queen's Medical Research Institute (QMRI), University of Edinburgh, 47 Little France, Bioquarter, Edinburgh EH16 4TJ, United Kingdom.
³ Centre for Cardiovascular Science, Queen's Medical Research Institute (QMRI), University of Edinburgh, 47 Little France, Bioquarter, Edinburgh EH16 4TJ, United Kingdom; Department of Pathology, Experimental Vascular Pathology Group, Maastricht University, PO box 5800, 6202 AZ, Maastricht, the Netherlands; Department for Renal and Hypertensive, Rheumatological and Immunological Diseases (Medical Clinic II), RWTH Aachen, Aachen, Germany.
⁴ Department of Pharmacological and Biomolecular Sciences 'Rodolfo Paoletti', Università degli Studi di Milano, Milan, Italy; IRCCS MultiMedica, Milan, Italy.
⁵ Cardiovascular Research Unit, Department of Precision Health, Luxembourg Institute of Health, Strassen, Luxembourg.

No abstract available

Keywords: Atherosclerosis; Cardiovascular disease; Mutliomics.

Conflict of interest statement

Declaration of competing interest The authors declare no conflict of interest.